← Every applicant
Twi Pharms FDA Approvals
11 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| CYCLOSPORINENew drugJan 21, 2026EMULSION, OPHTHALMIC |
| KLOR-CONNew drugOct 28, 2024TABLET, EXTENDED RELEASE, ORAL |
| TOPIRAMATENew drugDec 5, 2023CAPSULE, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugJun 1, 2023TABLET, ORAL |
| DILTIAZEM HYDROCHLORIDENew drugMar 1, 2023CAPSULE, EXTENDED RELEASE, ORAL |
| DICYCLOMINE HYDROCHLORIDENew drugDec 27, 2022CAPSULE, ORAL |
| DEXLANSOPRAZOLENew drugSep 16, 2022CAPSULE, DELAYED RELEASE, ORAL |
| FLUPHENAZINE HYDROCHLORIDENew drugApr 1, 2022TABLET, ORAL |
| MYCOPHENOLATE SODIUMNew drugNov 3, 2021TABLET, DELAYED RELEASE, ORAL |
| METFORMIN HYDROCHLORIDENew drugSep 29, 2021TABLET, EXTENDED RELEASE, ORAL |
| TESTOSTERONENew drugSep 3, 2021SOLUTION, METERED, TRANSDERMAL |